Atlas Trials

Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study

Clinical trial NCT06957834 · COMPLETED

Trial details

NCT number
NCT06957834
Sponsor
National Skin Centre
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melasma
Start date
2023-06-06
Primary completion
2024-07-11
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.